Lawrie Wheeler
Queensland University of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lawrie Wheeler.
Human Mutation | 2016
Aideen McInerney-Leo; Jessica Harris; Michael Gattas; Elizabeth E. Peach; Stephen Sinnott; Tracy Dudding-Byth; Sulekha Rajagopalan; Christopher Barnett; Lisa Anderson; Lawrie Wheeler; Matthew A. Brown; Paul Leo; Carol Wicking; Emma L. Duncan
Fryns syndrome is an autosomal recessive condition characterized by congenital diaphragmatic hernia (CDH), dysmorphic facial features, distal digital hypoplasia, and other associated malformations, and is the most common syndromic form of CDH. No gene has been associated with this condition. Whole‐exome sequence data from two siblings and three unrelated individuals with Fryns syndrome were filtered for rare, good quality, coding mutations fitting a recessive inheritance model. Compound heterozygous mutations in PIGN were identified in the siblings, with appropriate parental segregation: a novel STOP mutation (c.1966C>T: p.Glu656X) and a rare (minor allele frequency <0.001) donor splice site mutation (c.1674+1G>C) causing skipping of exon 18 and utilization of a cryptic acceptor site in exon 19. A further novel homozygous STOP mutation in PIGN (c.694A>T: p.Lys232X) was detected in one unrelated case. All three variants affected highly conserved bases. The two remaining cases were negative for PIGN mutations. Mutations in PIGN have been reported in cases with multiple congenital anomalies, including one case with syndromic CDH. Fryns syndrome can be caused by recessive mutations in PIGN. Whether PIGN affects other syndromic and non‐syndromic forms of CDH warrants investigation.
Genome Medicine | 2017
Jacob Gratten; Qiong-Yi Zhao; Beben Benyamin; Fleur C. Garton; Ji He; Paul Leo; Marie Mangelsdorf; Lisa Anderson; Zong Hong Zhang; Lu Chen; Xiang-Ding Chen; Katie Cremin; Hong-Weng Deng; Janette Edson; Ying-Ying Han; Jessica Harris; Anjali K. Henders; Zi-Bing Jin; Zhongshan Li; Yong Lin; Xiaolu Liu; Mhairi Marshall; Bryan J. Mowry; Shu Ran; David C. Reutens; Sharon Song; Li-Jun Tan; Lu Tang; Robyn H. Wallace; Lawrie Wheeler
BackgroundAmyotrophic lateral sclerosis (ALS) is a progressive neurological disease characterised by the degeneration of motor neurons, which are responsible for voluntary movement. There remains limited understanding of disease aetiology, with median survival of ALS of three years and no effective treatment. Identifying genes that contribute to ALS susceptibility is an important step towards understanding aetiology. The vast majority of published human genetic studies, including for ALS, have used samples of European ancestry. The importance of trans-ethnic studies in human genetic studies is widely recognised, yet a dearth of studies of non-European ancestries remains. Here, we report analyses of novel whole-exome sequencing (WES) data from Chinese ALS and control individuals.MethodsWES data were generated for 610 ALS cases and 460 controls drawn from Chinese populations. We assessed evidence for an excess of rare damaging mutations at the gene level and the gene set level, considering only singleton variants filtered to have allele frequency less than 5 × 10–5 in reference databases. To meta-analyse our results with a published study of European ancestry, we used a Cochran–Mantel–Haenszel test to compare gene-level variant counts in cases vs controls.ResultsNo gene passed the genome-wide significance threshold with ALS in Chinese samples alone. Combining rare variant counts in Chinese with those from the largest WES study of European ancestry resulted in three genes surpassing genome-wide significance: TBK1 (p = 8.3 × 10–12), SOD1 (p = 8.9 × 10–9) and NEK1 (p = 1.1 × 10–9). In the Chinese data alone, SOD1 and NEK1 were nominally significantly associated with ALS (p = 0.04 and p = 7 × 10–3, respectively) and the case/control frequencies of rare coding variants in these genes were similar in Chinese and Europeans (SOD1: 1.5%/0.2% vs 0.9%/0.1%, NEK1 1.8%/0.4% vs 1.9%/0.8%). This was also true for TBK1 (1.2%/0.2% vs 1.4%/0.4%), but the association with ALS in Chinese was not significant (p = 0.14).ConclusionsWhile SOD1 is already recognised as an ALS-associated gene in Chinese, we provide novel evidence for association of NEK1 with ALS in Chinese, reporting variants in these genes not previously found in Europeans.
RMD Open | 2018
Margarida Santos; Ana Rita Couto; Iris Foroni; Bruno Filipe Bettencourt; Zhixiu Li; Raquel Meneses; Lawrie Wheeler; Joaquim Polido Pereira; Fernando M. Pimentel-Santos; João Eurico Fonseca; Helena Alves; António Martinho; Manuela Lima; Matthew A. Brown; Jácome Bruges-Armas
Objectives Ankylosing spondylitis (AS) is the most prevalent form of spondyloarthritis, with a known genetic association with the HLA-B27 molecule. The aim of this study was to assess the contribution of the HLA-G, HLA-E and HLA-F to AS susceptibility/protection in Portuguese patients with HLA-B27 AS and HLA-B27 unaffected controls. Methods High-resolution typing of HLA-G, HLA - E and HLA - F was performed in 228 patients with HLA-B27 AS and 244 HLA-B27 unaffected controls. Allelic, genotypic and haplotypic frequencies were compared between cohorts. To replicate the results, single nucleotide polymorphisms (SNPs) in HLA-E and HLA-F genes were typed in Australian cohorts. For further confirmation, a group of European-descent patients with AS and unaffected controls were genotyped for Major Histocompatibility Complex SNPs using the Illumina microarray. Results In the Portuguese population, no significant differences were found in HLA-G. For HLA-E, a significant difference was detected for the genotype HLA-E*01:01:01/01:03:01 (p=0.009; pc=0.009; OR=0.51), with a protection effect. For HLA-F, significant differences were detected in the allele HLA-F*01:01:02 (p=0.0049; pc=0.0098; OR=0.60) and corresponding SNP rs2075682 (p=0.0004; pc=0.0008; OR=0.53), suggesting protection and in the genotype HLA-F*01:01:01/01:03:01 (p=0.011; pc=0.043; OR=2.00), suggesting a susceptibility effect. Three G-E-F haplotypes with significant differences were detected but occur in a very small number of individuals. The only significant differences detected in the replication studies were for HLA-E rs1059510 in the Australians and for HLA-F rs1736924 in the European-descent cohorts. Conclusion Our results reveal suggestive AS protective and susceptibility effects from both HLA-E and HLA - F loci, however with population differences. To our knowledge, this is the first study showing association of HLA-F with AS.
British Journal of Dermatology | 2018
Aideen McInerney-Leo; Lawrie Wheeler; Richard A. Sturm; J.-M. Tan; Jessica Harris; Lisa Anderson; Kasturee Jagirdar; Matthew A. Brown; Paul Leo; Hans Peter Soyer; Emma L. Duncan
Research letter Dear Editor, Rarely, melanoma is dominantly inherited, with CDKN2A mutations accounting for > 85% of mutation‐positive families.1 CDKN2A encodes two, nonhomologous proteins, p16 and p14ARF, with individually unique first exons (1α and 1β, respectively) and alternative reading frames. Over 95% of the CDKN2A mutations in familial melanoma occur in the p16 transcript...
Annals of the Rheumatic Diseases | 2018
Adrian Cortes; Dafna D. Gladman; Soumya Raychaudhuri; Jing Cui; Lawrie Wheeler; Matthew A. Brown
Ankylosing spondylitis (AS) susceptibility is strongly correlated with genetic variation within the major histocompatibility complex (MHC), and the class I HLA-B*27 allele confers the major genetic risk factor to AS. Furthermore, strong evidence for additional alleles in the MHC has been observed which affect susceptibility independently from the HLA-B*27 allele, either by direct genotyping in candidate gene studies or through large-scale imputation-driven association studies. We have previously identified variants in both class I and II which affect susceptibility to AS through imputation of classical HLA alleles...
School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation | 2016
Aideen McInerney-Leo; Jessica Harris; Michael Gattas; Elizabeth E. Peach; Stephen Sinnott; Tracy Dudding-Byth; Sulekha Rajagopalan; Christopher Barnett; Lisa Anderson; Lawrie Wheeler; Matthew A. Brown; Paul Leo; Carol Wicking; Emma L. Duncan
School of Biomedical Sciences; Institute of Health and Biomedical Innovation | 2018
Aideen McInerney-Leo; Lawrie Wheeler; Richard A. Sturm; J.-M. Tan; Jessica Harris; Lisa Anderson; Kasturee Jagirdar; Brown; Paul Leo; Hp Soyer; Emma L. Duncan
School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation | 2018
Elisabeth De Smit; Samuel W. Lukowski; Lisa Anderson; Anne Senabouth; Kaisar Dauyey; Sharon Song; Bruce Wyse; Lawrie Wheeler; Christine Y. Chen; Khoa Cao; Amy Wong Ten Yuen; Neil Shuey; Linda Clarke; Isabel Lopez Sanchez; Sandy S. C. Hung; Alice Pébay; David A. Mackey; Matthew A. Brown; Alex W. Hewitt; Joseph E. Powell
School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation | 2017
Aideen McInerney-Leo; Lawrie Wheeler; Mhairi Marshall; Lisa Anderson; Andreas Zankl; Matthew A. Brown; Paul Leo; Carol Wicking; Emma L. Duncan
School of Biomedical Sciences; Faculty of Health | 2017
Beben Benyamin; Ji He; Qiong-Yi Zhao; Jacob Gratten; Fleur C. Garton; Paul Leo; Zhijun Liu; Marie Mangelsdorf; Ammar Al-Chalabi; Lisa Anderson; Tim J. Butler; Lu Chen; Xiang-Ding Chen; Katie Cremin; Hong-Weng Deng; Matthew S. Devine; Janette Edson; Jennifer A. Fifita; Sarah Furlong; Ying-Ying Han; Jessica Harris; Anjali K. Henders; Rosalind L. Jeffree; Zi-Bing Jin; Zhongshan Li; Ting Li; Mengmeng Li; Yong Lin; Xiaolu Liu; Mhairi Marshall